Malta - engleză - Malta Medicines Authority

noridem enterprises ltd evagorou & makariou, mitsi building 3, office 115,1065 nicosia, cyprus - sodium chloride - solution for injection - sodium chloride 9 mg/ml - all other non-therapeutic products

Malta - engleză - Malta Medicines Authority

noridem enterprises ltd evagorou & makariou, mitsi building 3, office 115,1065 nicosia, cyprus - sodium chloride - solution for injection - sodium chloride 9 mg/ml - all other non-therapeutic products

Malta - engleză - Malta Medicines Authority

noridem enterprises ltd evagorou & makariou, mitsi building 3, office 115,1065 nicosia, cyprus - sodium chloride - solution for injection - sodium chloride 9 mg/ml - all other non-therapeutic products

Arabia Saudită - engleză - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

pharmaceutical solution industries (psi), saudi arabia - dextrose monohydrate, sodium chloride, potassium chloride, calcium chloride 2h2o, sodium lactate solution - solution for injection - 55 , 6 , 0.40 , 0.27 , 3.20 g/ml

Singapore - engleză - HSA (Health Sciences Authority)

joyson pte. ltd. - dextrose monohydrate; sodium chloride - injection - 5 g/100 ml - dextrose monohydrate 5 g/100 ml; sodium chloride 450 mg/100 ml

Singapore - engleză - HSA (Health Sciences Authority)

joyson pte. ltd. - dextrose monohydrate; sodium chloride - injection - 5 g/100 ml - dextrose monohydrate 5 g/100 ml; sodium chloride 900 mg/100 ml

Filipine - engleză - FDA (Food And Drug Administration)

optimum trading - dextrose in sodium chloride - solution for iv infusion - 5% in 0.9%

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

becton dickinson and company - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok) - dextrose monohydrate 50 mg in 1 ml - intravenous solutions containing dextrose are indicated for parenteral replenishment of fluid and minimal carbohydrate calories as required by the clinical condition of the patient. 5% dextrose injection, usp without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur. check flexible container solution composition, lot number, and expiry date. do not remove solution container from its overwrap until immediately before use. use sterile equipment and aseptic technique. to open - turn solution container over so that the text is face down. using the pre-cut corner tabs, peel open the overwrap and remove solution container. - check the solution container for leaks by squeezing firmly. if leaks are found, or if the seal is not intact, discard the solution. - do not use if the solution is cloudy or a precipitate is present. to add medication - identify white additive port with arrow pointing toward

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

baxter healthcare corporation - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (sodium cation - unii:lyr4m0nh37, lactic acid - unii:33x04xa5at), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698), magnesium chloride (unii: 02f3473h9o) (magnesium cation - unii:t6v3lhy838, chloride ion - unii:q32zn48698) - dextrose monohydrate 1.5 g in 100 ml - dianeal peritoneal dialysis solutions are indicated for patients in acute or chronic renal failure. dianeal peritoneal dialysis solutions are contraindicated in patients with severe lactic acidosis. dianeal peritoneal dialysis solution is a pharmacologically inactive solution. while there are no adequate and well controlled studies in pregnant women, appropriate administration of dianeal solutions, with appropriate monitoring of hematology, electrolytes, blood chemistry and fluid status is not expected to cause fetal harm. animal reproduction studies have not been conducted with dianeal solutions. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. the components of dianeal solutions are excreted in human milk. safety and effectiveness have been established based on published clinic

Statele Unite ale Americii - engleză - NLM (National Library of Medicine)

b. braun medical inc. - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), sodium lactate (unii: tu7hw0w0qt) (lactic acid - unii:33x04xa5at), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), calcium chloride (unii: m4i0d6vv5m) (calcium cation - unii:2m83c4r6zb, chloride ion - unii:q32zn48698) - dextrose monohydrate 5 g in 100 ml - this solution is indicated for use in adults and pediatric patients as a source of electrolytes, calories and water for hydration. the use of 5% dextrose in lactated ringer’s injection is contraindicated in neonates (28 days of age or younger) receiving concomitant treatment with ceftriaxone, even if separate infusion lines are used, due to the risk of fatal ceftriaxone-calcium salt precipitation in the neonate’s bloodstream [see warnings, drug interactions, pediatric use ]. this solution is contraindicated where the administration of sodium, potassium, calcium, chloride or lactate could be clinically detrimental. lactate administration is contraindicated in severe metabolic acidosis or alkalosis, and in severe liver disease or anoxic states which affect lactate metabolism. solutions containing dextrose may be contraindicated in patients with hypersensitivity to corn products.